staurosporine has been researched along with Hyperplasia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, IL; Kim, SY; Kwon, YW; Park, SG; Sung, JH | 1 |
| Shibasaki, M; Tahara, A; Tomura, Y; Tsukada, J; Yatsu, T | 1 |
| Heikkilä, P; Kahri, AI; Liu, J; Voutilainen, R | 1 |
| Bishop, WR; Fisher, GJ; McCombie, SW; Reynolds, NJ; Shankar, BB | 1 |
| Aizu, E; Hosoda, Y; Kato, R; Kiyoto, I; Nakadate, T; Yamamoto, S | 1 |
| Chida, K; Hirota, K; Kuroki, T; Yamada, S | 1 |
6 other study(ies) available for staurosporine and Hyperplasia
| Article | Year |
|---|---|
Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
Topics: Animals; Apoptosis; Biological Transport; Carotid Artery Injuries; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Dual Specificity Phosphatase 1; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Hyperplasia; Liver-Specific Organic Anion Transporter 1; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Protein Kinase C-alpha; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; RNA Interference; Staurosporine; Taurochenodeoxycholic Acid; Time Factors; Transfection; Tunica Intima; Up-Regulation | 2011 |
Effects of high glucose on AVP-induced hyperplasia, hypertrophy, and type IV collagen synthesis in cultured rat mesangial cells.
Topics: Animals; Antidiuretic Agents; Arginine Vasopressin; Cells, Cultured; Collagen Type IV; Diabetic Nephropathies; Enzyme Inhibitors; Glomerular Mesangium; Hyperglycemia; Hyperplasia; Hypertrophy; Mesangial Cells; Rats; Rats, Wistar; Staurosporine | 2012 |
Ribonucleic acid expression of the CLA-1 gene, a human homolog to mouse high density lipoprotein receptor SR-BI, in human adrenal tumors and cultured adrenal cells.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Blotting, Northern; Bucladesine; CD36 Antigens; Cells, Cultured; Cushing Syndrome; Gene Expression; Humans; Hyperplasia; Membrane Proteins; Mice; Molecular Sequence Data; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; RNA, Messenger; Scavenger Receptors, Class B; Staurosporine; Tetradecanoylphorbol Acetate | 1997 |
SCH 47112, a novel staurosporine derivative, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and epidermal hyperplasia in hairless mouse skin.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Enzyme Inhibitors; Epidermis; Humans; Hyperplasia; Keratinocytes; Male; Mice; Mice, Hairless; Molecular Structure; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate | 1997 |
Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkaloids; Animals; Edema; Enzyme Induction; Female; Hyperplasia; Inflammation; Kinetics; Mice; Mice, Inbred Strains; Ornithine Decarboxylase; Protein Kinase C; Reference Values; Skin; Skin Neoplasms; Staurosporine; Superoxides; Tetradecanoylphorbol Acetate | 1989 |
Inhibition of phorbol ester-caused induction of ornithine decarboxylase and tumor promotion in mouse skin by staurosporine, a potent inhibitor of protein kinase C.
Topics: Alkaloids; Animals; Cocarcinogenesis; Enzyme Induction; Hyperplasia; Mice; Ornithine Decarboxylase; Protein Kinase C; Skin Neoplasms; Staurosporine; Tetradecanoylphorbol Acetate | 1988 |